Balyasny Asset Management’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-150,000
Closed -$6.02M 3250
2025
Q1
$6.02M Buy
+150,000
New +$6.31M 0.01% 1159
2023
Q4
Sell
-183,896
Closed -$7.9M 2822
2023
Q3
$7.9M Buy
+183,896
New +$8.57M 0.02% 932
2023
Q2
Sell
-61,299
Closed -$2.99M 2688
2023
Q1
$2.99M Buy
+61,299
New +$3.12M 0.01% 1290
2022
Q4
Sell
-183,896
Closed -$8.05M 3147
2022
Q3
$8.05M Buy
+183,896
New +$9.08M 0.02% 783
2022
Q2
Sell
-132,028
Closed -$6.86M 3093
2022
Q1
$6.86M Buy
+132,028
New +$6.81M 0.02% 831
2021
Q4
Sell
-665,986
Closed -$36.5M 2531
2021
Q3
$36.5M Buy
+665,986
New +$37.1M 0.15% 172
2020
Q4
Sell
-117,882
Closed -$6.53M 1625
2020
Q3
$6.53M Buy
117,882
+10,751
+10% +$558K 0.05% 517
2020
Q2
$4.8M Buy
+107,131
New +$4.79M 0.04% 534
2017
Q2
Sell
-94,306
Closed -$2.9M 1688
2017
Q1
$2.9M Sell
94,306
-45,273
-32% -$1.4M 0.01% 826
2016
Q4
$4.3M Buy
+139,579
New +$4.16M 0.02% 725

Other funds holding QGEN

Balyasny Asset Management's QGEN Position: Q1 2026 in Review

Balyasny Asset Management reduced its Qiagen (QGEN) stake by 0.73% in Q1 2026, selling an estimated $151K and leaving 433,592 shares worth $17.4M. The position accounts for 0.02% of the portfolio, ranked #748.

Balyasny Asset Management first reported a position in QGEN in Q4 2016 and has held it in 33 quarters since. The position peaked at $88.7M in Q3 2021. 344 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

  • Balyasny Asset Management held 433,592 shares of Qiagen worth $17.4M as of Q1 2026.
  • Balyasny Asset Management sold 3,190 Qiagen shares in Q1 2026, an estimated $151K.
  • Qiagen made up 0.02% of Balyasny Asset Management's portfolio in Q1 2026, its #748 holding.
  • Balyasny Asset Management first reported a position in Qiagen in Q4 2016 and has held it in 33 quarters since.
  • Balyasny Asset Management's Qiagen position peaked at $88.7M in Q3 2021.
  • 344 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.